Introduction {#s1}
============

Gait, a complex sensorimotor behavior involving coordination of neural networks, bones, muscles and joints, requires sensory information to aid in control of movement and to influence gait adaptation (Barbieri and Vitório, [@B1]). Effective integration of concurrent sensory stimulation is crucial for successful mobility. In our previous work, we demonstrate a protective effect of multisensory integration in aging whereby greater ability to integrate visual and somatosensory information was associated with increased balance performance, and decreased likelihood of falls (Mahoney et al., [@B22], [@B20]).

To our knowledge, the association between visual-somatosensory (VS) integration and gait performance has not been established. Verghese and colleagues identified three independent gait domains using a factor analysis approach (Pace, Rhythm, and Variability; see Verghese et al., [@B35]). The pace factor encompasses spatial parameters including gait speed, stride length, and percentage of gait cycle spent in double support (i.e., immobilized with two feet on the ground), whereas the rhythm factor includes temporal parameters such as cadence (number of steps per minute), swing time and stance time. The variability factor quantifies inconsistencies (measured in standard deviation units) of the highest loading gait variables of both spatial (stride length) and temporal (swing time) domains. Noteworthy, these gait domains have been verified by other investigators (Hollman et al., [@B13]; Lord et al., [@B19]; Verlinden et al., [@B36]).

Neuroimaging of the brain during walking has not been perfected yet; however existing models of locomotion reveal associations of neural activation in cortical (frontal/supplementary motor/parietal), subcortical (basal ganglia/thalamus), cerebellar, and brainstem regions with mobility outcomes (Holtzer et al., [@B14]). Noteworthy, multisensory integration effects have also been linked to cortical \[frontal/motor/primary sensory areas/superior temporal sulcus (STS)\] and subcortical (superior colliculus/thalamus) regions in cats, primates, and humans (Meredith and Stein, [@B26]; Stein et al., [@B31]; Calvert et al., [@B5]; Schroeder and Foxe, [@B29]). Given noticeable overlaps in the neural circuitry necessary for both sensory integration and goal-directed locomotion through space (sensory/motor regions, basal ganglia, and thalamus to name a few), we hypothesize that VS integration will be significantly associated with spatial aspects of gait (pace) and not with temporal aspects of gait (rhythm) which appear to be more automatic processes, influenced less by sensory inputs, and controlled mainly through brainstem and spinal networks (Kandel et al., [@B17]). The variability factor encompasses aspects of both pace and rhythm that could collectively be associated with VS integration; however, if our above hypothesis is supported, then VS integration should only be associated with stride length variability and not swing time variability.

Material and methods {#s2}
====================

Participants
------------

Three-hundred-ninety-five participants enrolled in the Central Control of Mobility in Aging (CCMA) study at the Albert Einstein College of Medicine in Bronx, New York completed a multisensory simple reaction time (RT) experiment between June 2011 and June 2018. CCMA eligibility criteria required that participants be 65 years of age and older, reside in lower Westchester county, and speak English. Exclusion criteria for the CCMA included inability to independently ambulate, presence of dementia, significant bilateral vision, and/or hearing loss, active neurological or psychiatric disorders that would interfere with evaluations, recent or anticipated medical procedures that would affect mobility, and/or receiving hemodialysis treatment (see also Holtzer et al., [@B15],[@B16]). Presence of dementia was excluded using reliable cut scores from the AD8 Dementia Screening Interview (cutoff score ≥2; Galvin et al., [@B9], [@B10]) and the Memory Impairment Screen (MIS; cutoff score \< 5; Buschke et al., [@B4]); and later confirmed using consensus clinical case conference.

Additional exclusion criteria included history of severe unilateral vision (*n* = 5) and/or hearing loss (*n* = 4). All participants were required to successfully complete a sensory screening exam, where visual, auditory, and somatosensory acuity were formally tested to ensure appropriateness for the study. All CCMA participants were required to have bilateral visual acuity that was better or equal to 20/100 as measured by the Snellen eye chart. Individuals that were unable to hear a 2,000 Hz tone at 25 dB in both ears were not included in the CCMA study. As in our previous studies, presence or absence of neuropathy was diagnosed by the study clinician, and participants with severe neuropathy (unable to feel somatosensory stimulation) were not included (Mahoney et al., [@B22], [@B21], [@B20]). Additional exclusion criteria included inadequate multisensory performance (*n* = 40; see below) and prevalent dementia at study enrollment (*n* = 13).

After exclusions, the total study sample consisted of 333 older adults (mean age 76.53 ± 6.22 years; 53% female). All participants provided written informed consent to the experimental procedures, which were approved by the institutional review board of the Albert Einstein College of Medicine, Bronx, NY in accordance with the *Declaration of Helsinki*.

Stimuli, task, and responses
----------------------------

Visual, somatosensory (vibratory pulses), and simultaneous VS stimuli were delivered through a custom-built stimulus generator (Zenometrics, LLC; Peekskill, NY, USA) that consisted of two control boxes, each housing a 15.88 cm diameter blue light emitting diodes (LEDs) and a 30.48 × 20.32 × 12.70 mm plastic housing containing a vibrator motor with 0.8 G vibration amplitude (Mahoney et al., [@B21], [@B20]; Dumas et al., [@B8]). The devices were connected to a network control center, which allowed direct control for each device through the testing computer\'s parallel port. The devices were cycled on and off at precise predetermined intervals in any combination. A TTL (transistor-transistor-logic, 5 V, duration 100 ms) pulse was used to trigger the visual and somatosensory stimuli through E-Prime 2.0 software.

The control boxes were mounted to an experimental apparatus, which participants comfortably rested their hands upon, with their index fingers strategically placed over the vibratory motors on the back of the box and their thumb on the front of the box, under the LED (see Figure [1](#F1){ref-type="fig"}). A third dummy control box was placed in the center of the actual control boxes, at an equidistant length (28 cm) and contained a bull\'s eye sticker with a central circle of 0.4 cm diameter which served as the fixation point. To ensure that the somatosensory stimuli were inaudible, each participant was provided with headphones over which continuous white noise was played.

![Experimental apparatus. Participants were required to make speeded responses to bilateral visual, somatosensory, and visual-somatosensory stimuli by pressing a foot pedal located under their right foot (Mahoney et al., [@B21]).](fnagi-10-00377-g0001){#F1}

The three conditions were presented randomly with equal frequency and consisted of three blocks of 45 trials, for a total of 135 stimuli. Each block was separated by a 20 s break in order to reduce fatigue and facilitate concentration, and each subsequent block commenced immediately after the conclusion of the break. Participants were instructed to respond to all stimuli by pressing a stationary pedal located under their right foot as quickly as possible. Performance accuracy was defined as the number of accurate stimulus detections divided by 45 trials per condition. To prevent anticipatory effects, the inter-stimulus-interval varied randomly from 1 to 3 s. The duration of the entire experiment was approximately 7 min.

As in our previous multisensory studies, a 70% performance accuracy cutoff for all conditions was implemented to exclude participants with unreliable responses (*n* = 40; Mahoney et al., [@B22], [@B21], [@B20]). To be consistent with (Mahoney et al., [@B20]), data trimming procedures were purposefully avoided so as to not bias the distribution of the RT data (see Gondan and Minakata, [@B12]). If the participant failed to respond to any given stimulus, then that trial was considered inaccurate (omitted) and the corresponding RT was set to infinity rather than excluded from the analysis (Gondan and Minakata, [@B12]; Mahoney et al., [@B20]). To facilitate comparisons to other multisensory studies, the overall RT (average of all RTs regardless of condition) and overall RT facilitation effect (i.e., RT difference between the multisensory VS condition and the fastest unisensory condition) is included in Table [1](#T1){ref-type="table"}.

###### 

Demographic and clinical characteristics of study sample overall and by classification[^\*^](#TN1){ref-type="table-fn"}.

  **Variable**                                       **Overall cohort (*n* = 333)**   **Superior (*n* = 95)**    **Good (*n* = 87)**         **Poor (*n* = 96)**          **Deficient (*n* = 55)**     ***p*-value [^∧^](#TN3){ref-type="table-fn"}**
  -------------------------------------------------- -------------------------------- -------------------------- --------------------------- ---------------------------- ---------------------------- ------------------------------------------------
  \% Female                                          53                               48                         55                          58                           47                           0.43
  \% Caucasian                                       77                               83                         72                          73                           80                           0.19
  \% Moderate Visual Impairment                      15                               13                         12                          20                           16                           0.39
  \% with Neuropathy                                 6                                6                          5                           5                            7                            0.91
  Age (years)                                        76.53 (6.22) 65--93              76.02 (5.84) 65--92        75.72 (5.67) 66--91         76.98 (6.85) 65--93          77.93 (6.38) 67--92          0.15
  Education (years)                                  15.02 (2.92) 5--21               15.14 (2.59) 8--21         15.10 (3.07) 5--21          15.08 (2.96) 8--21           14.54 (3.19) 7--21           0.62
  GHS (0--10)                                        1.14 (0.96) 0--4                 0.84 (0.83) 0--3           1.13 (0.96) 0--4            1.34 (0.94) 0--3             1.35 (1.09) 0--4             0.00
  RBANS Total Score (65--135)                        93.99 (11.59) 65--132            95.29 (11.65) 76--130      95.51 (11.11) 65--118       92.89 (10.90) 65--132        91.15 (12.94) 65--126        0.06
  Overall RT (ms)                                    403.35 (118.36) 243--1,322       391.79 (91.47) 258--822    387.19 (79.74) 243--764     401.65 (116.39) 248--944     451.85 (185.87) 278--1,322   0.01
  Somatosensory RT (ms)                              441.53 (121.49) 252--1,228       429.97 (103.04) 273--880   429.52 (92.71) 271--743     437.67 (118.39) 252--905     487.23 (176.89) 289--1,228   0.02
  Visual RT (ms)                                     404.95 (127.92) 233--1,425       395.95 (94.57) 262--805    387.58 (97.54) 233--1,050   404.58 (130.08) 250--1,019   448.58 (193.77) 275--1,425   0.04
  Multisensory VS RT (ms)                            364.37 (120.02) 213--1,318       349.84 (86.18) 239--781    346.44 (69.88) 226--617     362.71 (119.11) 213--914     420.74 (196.90) 245--1,318   0.00
  RT facilitation time (ms)                          30.36 (36.20) −135 to 148        38.07 (26.69) −45 to 148   33.88 (22.12) −24 to 84     26.71 (43.83) −135 to 132    17.83 (48.50) −123 to 112    0.08
  VS integration [^\#^](#TN2){ref-type="table-fn"}   0.04 (0.14) −0.32 to 0.41        0.16 (0.09) 0.04--0.41     0.08 (0.08) −0.05 to 0.30   −0.05 (0.12) −0.31 to 0.26   −0.11 (0.08) −0.32 to 0.01   0.00
  Velocity (cm/s)                                    100.35 (21.52) 49--167           105.46 (21.39) 55--167     102.60 (19.35) 60--150      96.60 (21.02) 49--143        94.47 (23.70) 52--153        0.00
  Stride Length (cm)                                 117.07 (18.91) 66--165           122.06 (17.91) 70--158     118.62 (16.50) 72--165      114.47 (18.67) 66--155       110.57 (22.13) 70--162       0.00
  Double Support %                                   31.50 (4.96) 18--48              30.52 (4.91) 18--48        30.59 (4.35) 22--45         32.44 (5.10) 21--48          32.99 (5.14) 23--47          0.00
  Swing Time (s)                                     0.40 (0.04) 0.27--0.59           0.40 (0.05) 0.31--0.59     0.40 (0.04) 0.32--0.49      0.40 (0.04) 0.27--0.51       0.39 (0.05) 0.27--0.57       0.29
  Cadence (steps/min)                                102.84 (11.45) 69--148           103.76 (12.25) 69--148     103.99 (11.10) 83--132      101.13 (10.83) 73--130       102.43 (11.53) 69--127       0.30
  Stance Time (s)                                    0.78 (0.11) 0.50--1.20           0.76 (0.10) 0.50--1.10     0.76 (0.10) 0.56--1.02      0.79 (0.11) 0.62--1.20       0.79 (0.12) 0.60--1.18       0.09
  Stride Length Variability (SD)                     3.70 (2.00) 0--13                3.53 (1.84) 1--13          3.32 (1.84) 0--8            3.99 (2.18) 1--13            4.07 (2.05) 1--10            0.05
  Swing Time Variability (SD)                        0.02 (0.01) 0.00--0.13           0.02 (0.02) 0.00--0.13     0.02 (0.01) 0.00--0.06      0.02 (0.01) 0.00--0.06       0.02 (0.02) 0.00--0.07       0.21

Values are presented as mean ± SD for continuous variables and % for dichotomous variable.

*Area under the curve of the CDF difference wave over the 0--10% percentile*.

*Result of Between Groups One-Way ANOVAs*.

Quantification of multisensory integration using the race model inequality
--------------------------------------------------------------------------

When two sources of sensory information are presented concurrently, they offer synergistic information that gives rise to faster responses, namely a redundant signals effect (Kinchla, [@B18]). Race models, commonly implemented to examine multisensory effects, are robust probability (P) models that compare the cumulative distribution function (CDF) of combined unisensory visual (V) and unisensory somatosensory (S) reaction times with an upper limit of one \[min \[P(RT~V~ ≤ *t*) + P(RT~S~ ≤ *t*), 1\] to the CDF of multisensory VS reaction times \[P(RT~VS~ ≤ *t*)\] (Miller, [@B28]; Maris and Maris, [@B24]; Colonius and Diederich, [@B6]). For any latency *t*, the race model inequality (RMI) *holds* when the CDF of the **actual** multisensory condition \[P(RT~VS~ ≤ *t)*\] is less than or equal to the **predicted CDF** \[min (P(RT~V~ ≤ *t*) + P(RT~S~ ≤ *t*), 1)\]. Note that these CDFs take all RTs into account and have been extensively reviewed and utilized in our previous studies (Mahoney et al., [@B21], [@B20]; Dumas et al., [@B8]). Acceptance of the above RMI suggests that unisensory signals are processed in parallel, such that the fastest unisensory signal could produce the actual response (i.e., the "winner" of the race). However, when the actual CDF is greater than the predicted CDF, the RMI is *rejected* and the RT facilitation is the result of multisensory interactions that allow signals from redundant information to integrate or combine non-linearly.

In order to calculate the race model violation, RTs must be sorted by condition in ascending order and the RT range across all stimulus (V, S, or VS) conditions must be calculated on an individual level. RT data are then quantized into 20 bins from the fastest RT (or zero percentile) to the slowest RT (hundredth percentile) in 5% increments (0%, 5%, ..., 95%, 100%) separately for each condition. For example, let us suppose that for one individual the fastest RT was equal to 100 ms and the longest RT was equal to 1,000 ms (regardless of stimulus condition). Here, the single fastest RT of 100 ms would be represented at the 0th percentile. The next cumulative percentile bin (5%), would take all RTs that fell within the 100 ms + \[5% of the range (1,000--100 ms = 900 ms range ^\*^ 5% = 45 ms)\] into account, so RTs between 100 and 145 ms. The 10% bin, would then consider RTs that were between 100 and 190 ms and so on until we reached the last RT (or 100%) percentile bin which would take all RTs from the 100--1,000 ms range into account. This method is implemented once for each of the three stimulus conditions and the probability of any RT occurring within each bin is calculated and transformed into a CDF. The CDF of the multisensory VS RTs represents the **actual** multisensory CDF, while the summation of the CDFs for both the visual and somatosensory CDFs (with an upper limit of 1) represents the **predicted** CDF. The difference in these two CDFs represents the Race Model inequality (RMI), where positive values are indicative of successful multisensory integration (also referred to as a violation of the race model). Figure [2](#F2){ref-type="fig"} depicts the group-averaged difference between **actual** and **predicted** CDFs (dashed trace), where positive values (shaded area between 0 and 10th percentile) are indicative of VS integration (i.e., *rejected* RMI). The RMI was tested using Gondan\'s permutation test [@B11] over the fastest 10% of responses and a robust violation was observed (*t*~max~ = 13.43, *t*~crit~ = 2.05, *p* \< 0.001).

![Test of the race model. The CDF difference waves over the trajectory of averaged responses for the entire study cohort (dashed trace) and for each of the four multisensory integration classifications (solid traces).](fnagi-10-00377-g0002){#F2}

As in our previous study (Mahoney et al., [@B20]), actual CDF difference values for these three *violated* percentile bins (0, 5, and 10%) were used to (1) calculate the *area-under-the-curve* (AUC) which served as our independent variable of 'magnitude of VS integration\' for further statistical modeling and (2) determine VS integration classification. VS integration classification was assigned based on the number of violated percentile bins (0, 1, 2, or 3) during the 0--10th percentile. Classification definition was operationalized as follows: if all percentile values *violated* the RMI the individual was considered a "superior" integrator; if two values *violated* the RMI, the individual was considered a "good" integrator; if one value *violated* the RMI, the individual was considered a "poor" integrator; and if zero values *violated* the RMI, the person was considered a "deficient" integrator." Figure [2](#F2){ref-type="fig"} also depicts race model difference waves by integration classification (solid grayscale traces).

Clinical evaluation
-------------------

Global cognitive status was assessed using the Repeatable Battery for Assessment of Neuropsychological Status (Duff et al., [@B7]). As in our previous studies, global health scores (range 0--10) were obtained from dichotomous rating (presence or absence) of physician diagnosed diabetes, chronic heart failure, arthritis, hypertension, depression, stroke, Parkinson\'s disease, chronic obstructive pulmonary disease, angina, and myocardial infarction (Mahoney et al., [@B23], [@B22], [@B21], [@B20]; Dumas et al., [@B8]).

Gait evaluation
---------------

Quantitative gait assessments were conducted using a 28-foot instrumented walkway with embedded pressure sensors that provide various spatial and temporal gait parameters (GAITRite, CIR Systems, Havertown, PA). GAITRite, a valid system for measuring gait performance with excellent test-retest reliability (Bilney et al., [@B2]; Menz et al., [@B25]; Brach et al., [@B3]), is widely used in clinical and research settings (Verghese et al., [@B33]). Here, steady-state locomotion was captured over a distance of 20 feet; data from the first and last 4 feet of the instrumented walkway (void of sensors) were purposefully excluded to eliminate initial acceleration and terminal deceleration. Participants were asked to walk on the mat at their "normal walking speed" in a quiet and well-lit room (see Verghese et al., [@B34]).

Similar to our previous work (Verghese et al., [@B35]), factor analysis using the principal component method was performed on eight individual spatiotemporal gait parameters: gait velocity, stride length, percentage of double support, stride time, stance time, cadence, stride length variability, and swing time variability. The advantage of a factor approach using orthogonal varimax rotation is to reduce a large number of potentially correlated variables (while retaining most of the information) into a smaller number of uncorrelated independent factors that reduces the redundancy across individual variables. We identified a total of three independent gait factors (namely: Pace, Rhythm, and Variability) which later served as dependent variables in subsequent analyses. The pace factor includes three spatial variables: gait velocity, stride length, and percentage of immobilized gait or double support. The rhythm factor includes three temporal variables: stride time, stance time, and cadence which is number of steps per minute. The variability factor comprised both spatial (stride length variability) and temporal (swing time variability) facets of gait measured in SD units.

Statistical analysis
--------------------

Data were inspected descriptively and graphically and the normality of model assumptions was formally tested. Descriptive statistics (M ± SD) were calculated for continuous variables and between group ANOVAs were conducted. All data analyses were run using IBM\'s Statistical Package for the Social Sciences (SPSS), Version 24.

Three linear regression analyses (one for each gait factor) were performed with pace, rhythm, or variability serving as the dependent variable and VS integration as the independent variable in unadjusted models. Additional covariates were entered in a stepwise manner. In Step 2, age and gender were added as independent variables. In Step 3, additional independent variables included presence of moderate visual loss, presence of mild neuropathy, and global health score. If adjusted associations were significant, additional sensitivity analyses were conducted to determine whether adjustments for Overall RT or RBANS Total Index score impacted the association of VS integration with the dependent measure. In an effort to further scrutinize the variability factor, given our *a priori* hypotheses, two additional regression models were conducted to examine the individual association of VS integration with spatial (stride length variability) and temporal (swing time variability) variability components.

Results {#s3}
=======

Demographic information is presented in Table [1](#T1){ref-type="table"} for both the overall cohort and for each multisensory classification group. Results demonstrate significant RMI violation over the fastest 10% of RTs using an established permutation test (Gondan, [@B11]); suggesting robust multisensory effects for the entire cohort. Difference values between actual and predicted CDFs were individually calculated for the *violated* percentile bins (0, 5, and 10%) and used to determine (1) multisensory integration classification group and (2) magnitude of VS integration. Based on our operational definition, our sample consisted of 95 superior integrators; 87 good integrators; 96 poor integrators; and 55 deficient integrators.

Factor analysis with varimax rotation yielded three orthogonal factors that accounted for over 87% of the variance in quantitative gait performance (Table [2](#T2){ref-type="table"}). The factor with the highest variance, pace, had strong loadings by spatial parameters including velocity, stride length, and percent of gait cycle spent immobilized (double support). The second factor, rhythm, had strong loadings by temporal parameters including swing time, stance time, and cadence (or number of steps per minute). The last factor, variability, loaded highly on stride length (spatial), and swing time (temporal) variability measures. Mean factor score was 0 (SD 1), and factor scores can be conceptualized as summary risk scores with high scores representing worse performance.

###### 

Factor loading of quantitative variables on three independent gait factors[^\#^](#TN4){ref-type="table-fn"}.

  **Gait variable**                **Pace**     **Rhythm**   **Variability**
  -------------------------------- ------------ ------------ -----------------
  Velocity (cm/s)                  **0.876**    −0.409       −0.106
  Stride length (cm)               **0.938**    0.080        −0.076
  Double support %                 −**0.897**   0.076        0.139
  Swing time (s)                   0.267        **0.933**    0.032
  Cadence (steps/min)              0.346        −**0.919**   −0.100
  Stance time (s)                  −0.560       **0.783**    0.113
  Stride length variability (SD)   −0.052       0.017        **0.950**
  Swing time variability (SD)      −0.472       0.245        **0.494**
  Variance explained %             39.78        32.09        15.08

*Rotation method: Varimax with Kaiser Normalization*.

Bold values indicate loadings.

Results from the linear regression analyses (Tables [3A--E](#T3){ref-type="table"}) reveal that VS integration processes, as quantified by the amount *area-under-the-curve* in the CDF difference wave, are associated with pace (β = 0.16, *p* ≤ 0.001) and variability (β = −0.12, *p* ≤ 0.04) factors, but not rhythm (β = 0.00, *p* = 1.00) in unadjusted models. The multisensory effect remained associated with pace even after controlling for age, gender, visual impairment, neuropathy, and global health score in models 2 through 3 (β = 0.12, *p* \< 0.05), but not variability (β = −0.11, *p* = 0.051). Given our hypothesis regarding the association of VS integration with spatial and not temporal gait factors, we further examined the association of multisensory integration with stride length variability and swing time variability separately. Our findings revealed that only stride length variability (spatial aspect) was associated with VS integration in fully adjusted models (β = −0.13, *p* \< 0.05). Sensitivity analyses further confirmed the significant association between VS integration and Pace even when adjusting for Overall RT (β = 0.13, *p* = 0.015) or RBANS Total index score (β = −0.13, *p* = 0.017). As well, the association between VS integration and Stride Length variability remained significant when adjusting for Overall RT (β = −0.12, *p* = 0.035) or RBANS Total index score (β = −0.13, *p* = 0.023).

###### 

**(A--E)** Summary of linear regression models for predicting gait factors and/or variables.

  **(A) Pace**   **Unstandardized coefficients**   **Standardized coefficients**   ***t***   **Sig**.   **95% confidence interval for B**   **Collinearity statistics**                          
  -------------- --------------------------------- ------------------------------- --------- ---------- ----------------------------------- ----------------------------- ------- ------- ------ ------
  1              **VS integration**                1.17                            0.40      0.16       2.96                                0.00                          0.39    1.95    1.00   1.00
  2              **VS integration**                0.93                            0.38      0.13       2.46                                0.01                          0.19    1.67    0.99   1.01
                 Age                               −0.05                           0.01      −0.28      −5.45                               0.00                          −0.06   −0.03   0.99   1.01
                 Gender                            −0.28                           0.10      −0.14      −2.70                               0.01                          −0.48   −0.08   1.00   1.00
  3              **VS integration**                0.85                            0.38      0.12       2.26                                0.03                          0.11    1.60    0.97   1.03
                 Age                               −0.05                           0.01      −0.28      −5.44                               0.00                          −0.06   −0.03   0.99   1.02
                 Gender                            −0.28                           0.10      −0.14      −2.69                               0.01                          −0.48   −0.08   0.98   1.02
                 Visual Impairment                 −0.14                           0.15      −0.05      −0.99                               0.32                          −0.43   0.14    0.97   1.03
                 Neuropathy                        −0.33                           0.23      −0.08      −1.47                               0.14                          −0.77   0.11    0.96   1.04
                 GHS Score                         −0.09                           0.05      −0.08      −1.61                               0.11                          −0.19   0.02    0.97   1.03

  **Model summary**                        
  ------------------- ------ ------ ------ ------
  1                   0.16   0.03   0.02   0.99
  2                   0.36   0.13   0.12   0.94
  3                   0.38   0.15   0.13   0.93

  **(B) Rhythm**   **Unstandardized coefficients**   **Standardized coefficients**   ***t***   **Sig**.   **95% Confidence Interval for B**   **Collinearity statistics**                          
  ---------------- --------------------------------- ------------------------------- --------- ---------- ----------------------------------- ----------------------------- ------- ------- ------ ------
  1                **VS integration**                0.00                            0.40      0.00       0.00                                1.00                          −0.79   0.79    1.00   1.00
  2                **VS integration**                −0.09                           0.39      −0.01      −0.22                               0.83                          −0.85   0.68    0.99   1.01
                   Age                               −0.01                           0.01      −0.03      −0.56                               0.58                          −0.02   0.01    0.99   1.01
                   Gender                            −0.51                           0.11      −0.26      −4.78                               0.00                          −0.72   −0.30   1.00   1.00
  3                **VS integration**                −0.08                           0.39      −0.01      −0.21                               0.83                          −0.86   0.69    0.97   1.03
                   Age                               −0.01                           0.01      −0.03      −0.52                               0.60                          −0.02   0.01    0.99   1.02
                   Gender                            −0.51                           0.11      −0.26      −4.75                               0.00                          −0.72   −0.30   0.98   1.02
                   Visual Impairment                 −0.09                           0.15      −0.03      −0.59                               0.56                          −0.39   0.21    0.97   1.03
                   Neuropathy                        −0.21                           0.23      −0.05      −0.90                               0.37                          −0.67   0.25    0.96   1.04
                   GHS Score                         0.01                            0.06      0.01       0.10                                0.92                          −0.11   0.12    0.97   1.03

  **Model summary**                        
  ------------------- ------ ------ ------ ------
  1                   0.00   0.00   0.00   1.00
  2                   0.26   0.07   0.06   0.97
  3                   0.27   0.07   0.05   0.97

  **(C) Variability**   **Unstandardized coefficients**   **Standardized coefficients**   ***t***   **Sig**.   **95% confidence interval for B**   **Collinearity statistics**                         
  --------------------- --------------------------------- ------------------------------- --------- ---------- ----------------------------------- ----------------------------- ------- ------ ------ ------
  1                     **VS integration**                −0.84                           0.40      −0.12      −2.11                               0.04                          −1.62   0.06   1.00   1.00
  2                     **VS integration**                −0.78                           0.40      −0.11      −1.96                               0.05                          −1.57   0.00   0.99   1.01
                        Age                               0.01                            0.01      0.09       1.59                                0.11                          0.00    0.03   0.99   1.01
                        Gender                            −0.06                           0.11      −0.03      −0.52                               0.60                          −0.27   0.16   1.00   1.00
  3                     **VS integration**                −0.79                           0.40      −0.11      −1.96                               0.05                          −1.59   0.00   0.97   1.03
                        Age                               0.01                            0.01      0.09       1.55                                0.12                          0.00    0.03   0.99   1.02
                        Gender                            −0.06                           0.11      0.03       −0.52                               0.60                          −0.28   0.16   0.98   1.02
                        Visual Impairment                 0.09                            0.16      0.03       0.58                                0.56                          −0.22   0.40   0.97   1.03
                        Neuropathy                        0.11                            0.24      0.03       0.46                                0.65                          −0.36   0.58   0.96   1.04
                        GHS Score                         −0.02                           0.06      0.02       −0.33                               0.74                          −0.13   0.10   0.97   1.03

  **Model summary**                        
  ------------------- ------ ------ ------ ------
  1                   0.12   0.01   0.01   0.99
  2                   0.15   0.02   0.01   0.99
  3                   0.15   0.02   0.01   1.00

  **(D) Stride length variability**   **Unstandardized coefficients**   **Standardized coefficients**   ***t***   **Sig**.   **95% confidence interval for B**   **Collinearity statistics**                          
  ----------------------------------- --------------------------------- ------------------------------- --------- ---------- ----------------------------------- ----------------------------- ------- ------- ------ ------
  1                                   **VS integration**                −1.93                           0.79      −0.13      −2.44                               0.02                          −3.49   −0.37   1.00   1.00
  2                                   **VS integration**                −1.83                           0.80      −0.13      −2.30                               0.02                          −3.39   −0.26   0.99   1.01
                                      Age                               0.03                            0.02      0.09       1.59                                0.11                          −0.01   0.06    0.99   1.01
                                      Gender                            −0.18                           0.22      −0.04      −0.82                               0.42                          −0.60   0.25    1.00   1.00
  3                                   **VS integration**                −1.81                           0.80      −0.13      −2.25                               0.03                          −3.39   −0.23   0.97   1.03
                                      Age                               0.03                            0.02      0.09       1.54                                0.12                          −0.01   0.06    0.99   1.02
                                      Gender                            −0.18                           0.22      −0.05      −0.83                               0.41                          −0.61   0.25    0.98   1.02
                                      Visual impairment                 0.20                            0.31      0.04       0.66                                0.51                          −0.41   0.81    0.97   1.03
                                      Neuropathy                        0.24                            0.48      0.03       0.51                                0.61                          −0.70   1.18    0.96   1.04
                                      GHS score                         0.00                            0.12      0.00       0.01                                1.00                          −0.23   0.23    0.97   1.03

  **Model summary**                        
  ------------------- ------ ------ ------ ------
  1                   0.13   0.02   0.02   1.98
  2                   0.16   0.03   0.02   1.98
  3                   0.17   0.03   0.01   1.98

  **(E) Swing Time Variability**   **Unstandardized coefficients**   **Standardized coefficients**   ***t***   **Sig**.   **95% confidence interval for B**   **Collinearity statistics**                         
  -------------------------------- --------------------------------- ------------------------------- --------- ---------- ----------------------------------- ----------------------------- ------- ------ ------ ------
  1                                **VS integration**                −0.01                           0.01      −0.10      −1.87                               0.06                          −0.02   0.00   1.00   1.00
  2                                **VS integration**                −0.01                           0.01      −0.08      −1.48                               0.14                          −0.02   0.00   0.99   1.01
                                   Age                               0.00                            0.00      0.21       3.81                                0.00                          0.00    0.00   0.99   1.01
                                   Gender                            0.00                            0.00      0.05       0.90                                0.37                          0.00    0.00   1.00   1.00
  3                                **VS integration**                −0.01                           0.01      −0.08      −1.46                               0.15                          −0.02   0.00   0.97   1.03
                                   Age                               0.00                            0.00      0.20       3.76                                0.00                          0.00    0.00   0.99   1.02
                                   Gender                            0.00                            0.00      0.05       0.90                                0.37                          0.00    0.00   0.98   1.02
                                   Visual Impairment                 0.00                            0.00      0.03       0.50                                0.62                          0.00    0.01   0.97   1.03
                                   Neuropathy                        0.00                            0.00      0.04       0.68                                0.50                          0.00    0.01   0.96   1.04
                                   GHS Score                         0.00                            0.00      0.00       −0.05                               0.96                          0.00    0.00   0.97   1.03

  **Model summary**                        
  ------------------- ------ ------ ------ ------
  1                   0.10   0.01   0.01   0.01
  2                   0.24   0.06   0.05   0.01
  3                   0.24   0.06   0.04   0.01

Discussion {#s4}
==========

The main objective of the current study was to determine whether ability to integrate concurrent VS information was associated with specific aspects of gait performance in older adults. Our findings reveal robust, but differential VS integration effects; 29% of the current study sample were superior VS integrators, while 26, 29, and 16% were considered good, poor, and deficient VS integrators, respectively. Our results demonstrate that magnitude of VS integration (i.e., *area-under-the-curve* in the CDF difference wave) was a strong predictor of spatial aspects of gait (i.e., pace factor). Magnitude of VS integration was not associated with temporal aspects of gait performance (rhythm), including swing time variability. The fact that magnitude of VS integration was however associated with stride length variability, does demonstrate a two-level dissociation between VS integration and spatial aspects of gait that is in keeping with our initial hypothesis.

In an effort to unpack the association of VS integration with spatial aspects of gait, we compared participants with poor or deficient multisensory integration abilities (*n* = 140) to those participants with superior or good multisensory integration abilities (*n* = 193). Results revealed that participants with good or superior VS integration maintained significantly faster gait velocity (103.55 vs. 95.93 cm/s; *p* = 0.001); longer strides (119.84 vs. 113.25 cm; *p* = 0.002); less percentage of gait cycle spent in double support (31 vs. 33%; *p* = 0.001) and less stride length variability (3.46 vs. 4.03 SD units: *p* = 0.01) compared to those with poor or deficient VS integration. While this information is helpful in characterizing the various spatial facets of gait, there are clear advantages to the application of a principal component approach when analyzing quantitative gait data.

Our finding that increased VS integration is linked to better goal-directed locomotion is directly in line with our hypothesis and likely a result of both processes activating similar neural circuitry. Multisensory integration effects have been linked to cortical \[frontal/motor/primary sensory areas/superior temporal sulcus (STS)\] and subcortical (superior colliculus/thalamus) regions in cats, primates, and humans (Meredith and Stein, [@B26]; Stein et al., [@B31]; Calvert et al., [@B5]). The lack of an association between VS integration and rhythm in our study could potentially be related to the fact that the temporal aspects of gait, emanating from brainstem and spinal networks, are less active during early, basic VS processing. While reports have indicated that multisensory inputs from brainstem can affect cortical integration processes, it is clear that the brainstem is primarily concerned with the temporal and spatial attributes of the sensory inputs, and thus the brainstem\'s role is more involved with modulation of information rather than information processing (Calvert et al., [@B5]).

Successful functioning and mobility in the real world rely on efficient multisensory integration processes that utilize feedback and feedforward neuronal loops between primary sensory, multisensory, and subcortical regions (see Calvert et al., [@B5]; Schroeder and Foxe, [@B29]; Meyer and Noppeney, [@B27]; Wallace, [@B37]). The thalamus plays an important role in the integration of sensory information, through cortico-cortical and cortical-subcortical transmissions (Sherman, [@B30]). Cortico-cortical and cortico-thalamic loops required for intact multisensory integration and mobility outcomes like balance and gait are notoriously compromised with aging. It is therefore logical that a disruption in shared neural circuitry, resulting from normal aging, disease, or any other potential variable, could adversely impact all processes relying on the functional and structural integrity of said circuit.

In an attempt to highlight the clinical significance of these findings, it should be noted that Verghese and colleagues posit that each 10 cm/s decrease in gait velocity is associated with a 7% increased risk for falls in our study populations (Verghese et al., [@B32]). The difference in gait velocity between the superior (105.46 cm/s) and deficient integrators (94.47 cm/s) was nearly 11 cm/s. Additionally, we recently revealed the clinical relevance of multisensory integration in aging in the context of balance and fall prediction (Mahoney et al., [@B20]) and our results indicate that older adults with superior VS integration abilities maintain: (1) better balance performance on the unipedal stance test (16.43 s) compared to deficient integrators (12.57 s) and (2) reduced occurrence of falls compared to deficient integrators for both prevalent (17 vs. 30%) and incident (42 vs. 80%) falls. Our initial studies highlight the significant association of VS integration (i.e., RT facilitation effect) with balance, falls, and physical activity level. However, the directionality of this association was seemingly paradoxical, where larger RT facilitation was associated with worse balance and increased falls (Mahoney et al., [@B22], [@B21]). While a significant association between VS integration and balance and falls still remains (Mahoney et al., [@B20]), we posit that the directionally of this association is likely influenced by methodological modifications which included a new operational definition of VS integration based on magnitude of race model violation (not RT facilitation) and avoidance of data-trimming procedures that reportedly skew the CDF (Gondan and Minakata, [@B12]).

In terms of study limitations, a healthy young control group was purposefully excluded given known alterations in unisensory processing with increasing age. The ability to image the brain in motion is essential to determine the actual neural networks associated with the independent gait factors of pace, rhythm, and variability; hopefully continued advances in technology will afford the opportunity to launch this investigation sooner rather than later. Lastly, while overall cognitive functioning as measured by the RBANS was not significantly different between groups, it is possible that better VS integration is associated with better cognition, which could in turn influence the relationship of VS integration with spatial aspects of gait. Future studies should aim to determine the impact of cognition or cognitive status on the association of VS integration and various motor outcomes.

In conclusion, we provide support for the association of increased VS integration with increased gait performance, particularly with regard to spatial aspects of gait (pace) for older adults. Our main finding reveals that deficits in VS integration are linked to slower gait speed, shorter strides, and increased percentage of gait cycle spend immobilized with two feet on the ground (double support %). Additionally, worse VS integration was associated with increased stride length variability which has already been linked to increased fall-risk for older adults. Therefore, the current study continues to provide support for the notion that inefficient multisensory integration may be a potential novel mechanism for falls in older adults.
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